Hospital de Amor

Name

Hospital de Amor

Legal name

Fundação Pio XII - Hospital de Amor

Website

https://hospitaldeamor.com.br

Company type

Private

Founded year

1962

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Oncology treatment services
• Cancer care hospital
• Medical residency programs
• Pediatric oncology services
• Cancer prevention education

Headquarters

HQ city

Barretos

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Public Health System (SUS) Reimbursement: Hospital de Amor operates as a public healthcare institution within Brazil's Unified Health System (SUS), receiving reimbursement for oncology services provided to referred patients.
2. Donations and Philanthropic Contributions: Individual and corporate donations managed through donation platform, with tax incentive programs under Lei Rouanet and IRHA (Incentivos Fiscais) for donors.
3. Public Subsidies: Municipal and state government subsidies supporting hospital operations as part of social responsibility programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Hospital de Amor is a philanthropic oncology hospital that delivers free, comprehensive cancer care — including surgery, chemotherapy, radiotherapy, nuclear medicine diagnostics, robotic surgery, rehabilitation, and palliative care — to patients of Brazil's public health system (SUS). It also runs medical residency programs across 19 oncology specialties, clinical research, and the PESCE school-based cancer prevention education program, all funded by SUS reimbursements, government subsidies, and charitable donations.

Product overview

Hospital de Amor is a comprehensive cancer treatment and prevention institution consisting of an adult hospital, a pediatric unit (Hospital de Amor Infantojuvenil), and prevention institutes across Brazil. The institution offers a full spectrum of oncology services spanning 19 medical residency specialties, nuclear medicine diagnostics and therapies, robotic surgery capabilities, and the PESCE health education program for schools. The hospital operates as a teaching institution under Fundação Pio XII, combining clinical care with medical education and research.

Differentiator

Problem solved

Functional benefit

Brands

• Instituto de Ensino e Pesquisa (IEP): Teaching and Research Institute that coordinates medical residency, research programs, and education initiatives.

Products and services

• Hospital de Amor Main Oncology Services Comprehensive cancer treatment and prevention services for adults referred through Brazil's SUS, including specialized oncology departments for head and neck, lower digestive, melanoma, thoracic, and urology cancers. Services include surgery, chemotherapy, radiotherapy, diagnostics, and rehabilitation, provided free of charge.
• Hospital de Amor Infantojuvenil (Pediatric Oncology Unit) Specialized pediatric oncology unit for children and adolescents, including retinoblastoma treatment and dedicated pediatric cancer care, designed in collaboration with St. Jude Children's Research Hospital. Provides age-separated infusion rooms, a rehabilitation center, chemotherapy center, and 24-hour emergency care.
• Nuclear Medicine Department Performs approximately 22,000 annual examinations and 300 therapies for various cancer types using four digital gamma cameras (one with simultaneous CT capability) and dedicated PET-CT equipment, certified Level III by ONA (Organização Nacional de Acreditação).
• Medical Residency Programs 98 annual medical residency positions across 19 specialties including Anesthesiology, Surgical Oncology, Clinical Oncology, Pediatric Oncology, Head and Neck Surgery, Endoscopy, Hematology, Mastology, Family Medicine, Intensive Care, Nuclear Medicine, Palliative Medicine, Pathology, Radiology, Radiotherapy, and Bone Marrow Transplant, supported by 206 preceptors with exclusive dedication.
• PESCE - Programa de Educação em Saúde e Câncer nas Escolas Health education program integrating education and health to promote cancer prevention awareness and healthy habits in school communities, applied across 11 innovative projects in 20+ cities and 82+ educational institutions, reaching 12,000+ students annually.
• Toumai MT-1000 Remote Robotic Surgery Service Remote robotic surgery service utilizing the Toumai MT-1000 system developed by Shanghai MicroPort MedBot, the world's only commercially available remote robotic surgery system with regulatory approval in 13 countries. Enables remote surgeries up to 1,400 km distance and is provided exclusively to SUS-referred oncology patients.

Quantifiable outcome

• Annual patient procedures increased from ~400 to 680 following robotic surgery system introduction
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

14 partnerships are on record, tiered core and minor.

• 22 Municipalities and 82 Educational InstitutionscoreStrategic or Co-development Partner · 1 January 2026PESCE 2026 program involves 22 municipalities, 82 educational institutions, and 15 partner institutions collaborating on cancer prevention education in schools.
• Shanghai MicroPort MedBotcoreTechnology or IntegrationShanghai MicroPort MedBot developed and supplies the Toumai MT-1000 remote robotic surgery system to Hospital de Amor. This is the world's only commercial remote robotic surgery system with regulatory approval in 13 countries, enabling Hospital de Amor to perform remote surgeries up to 1,400 km distance and set a world record for longest-distance remote surgery.
• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerSt. Jude Children's Research Hospital (the world's most prestigious pediatric oncology center) collaborated in the design of Hospital de Amor's pediatric oncology unit, contributing to international-standard architecture and operational protocols for childhood cancer treatment.
• Comissão Nacional de Residência Médica (CNRM)coreStrategic or Co-development PartnerCNRM (National Medical Residency Commission) is the regulatory body that accredits Hospital de Amor's 98 annual medical residency positions across 19 specialties.
• Associação de Medicina Intensiva Brasileira (AMIB)coreStrategic or Co-development PartnerAMIB provides accreditation for Hospital de Amor's Medical Intensive Care residency program alongside CNRM/MEC recognition.
• Sociedade Brasileira de MastologiacoreStrategic or Co-development PartnerAccredits Hospital de Amor's Mastology residency program alongside CNRM/MEC recognition.
• Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)coreStrategic or Co-development PartnerAccredits Hospital de Amor's Radiology and Diagnostic Imaging improvement program (6 positions annually).
• Sociedade De Endoscopia Digestiva (SOBED)coreStrategic or Co-development PartnerSOBED designates Hospital de Amor's Endoscopy service as a Center for Training (CET), offering endoscopy training positions in addition to CNRM residency spots.
• Breast Centres NetworkcoreStrategic or Co-development PartnerInternational network recognizing Hospital de Amor's breast unit as a Full Member, meeting international standards for breast cancer care.
• MD Anderson Cancer Center (Texas)minorStrategic or Co-development PartnerOptional elective rotation opportunity for Head and Neck Surgery residents at MD Anderson Cancer Center in Texas.
• Memorial Sloan Kettering Cancer Center (New York)minorStrategic or Co-development PartnerOptional elective rotation opportunity for Head and Neck Surgery residents at Memorial Sloan Kettering Cancer Center in New York.
• UNIFESP - IMIP - Hospital Criança de BrasíliaminorStrategic or Co-development PartnerPediatric oncology institutional collaboration for clinical meetings and knowledge exchange.
• Associação Voluntária de Combate ao Câncer de Barretos (AVCC)coreOthersAVCC Barretos manages charitable donations including caps and bottle caps recycling, providing materials and social support services for Hospital de Amor patients.
• International Lions Club FoundationminorStrategic or Co-development PartnerFoundation providing funding for advanced technologies in pediatric oncology treatment including retinoblastoma care.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/hospitaldeamor
• Facebookfacebook.com/ohospitaldeamor
• LinkedInlinkedin.com/company/hospitaldeamor
• Instagraminstagram.com/hospitaldeamor
• Xx.com/hospitaldeamor

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital de Amor